{"entity":{"type":"insider","cik":"0001268304","url":"/insider/0001268304","json_url":"/insider/0001268304.json","name":"IVERS-READ GILLIAN C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":92,"n_filings":55,"first":"2004-12-13","last":"2022-11-03","span_basis":"filed_date"},"name_variants":[{"name":"IVERS-READ GILLIAN C","source":"filing","n_filings":55,"first_seen":"2004-12-13","last_seen":"2022-11-03"}],"transactions":[{"id":6291486,"accession":"0000899243-22-034897","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-034897","line_url":"/filing/0000899243-22-034897","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3681.0,"shares_display":"3,681","price_per_share":0.9829,"price_display":"0.98","price_state":"stated","total_value":3618.0549,"total_display":"3,618.05","total_whole":"3,618","shares_owned_after":293612.0,"shares_owned_after_display":"293,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider","n_lines":2},{"id":6386398,"accession":"0000899243-22-030418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030418","line_url":"/filing/0000899243-22-030418#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2234.0,"shares_display":"2,234","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2680.8,"total_display":"2,680.80","total_whole":"2,681","shares_owned_after":288919.0,"shares_owned_after_display":"288,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6645490,"accession":"0000899243-22-027576","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027576","line_url":"/filing/0000899243-22-027576","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3802.0,"shares_display":"3,802","price_per_share":1.461,"price_display":"1.46","price_state":"stated","total_value":5554.722,"total_display":"5,554.72","total_whole":"5,555","shares_owned_after":286090.0,"shares_owned_after_display":"286,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6560547,"accession":"0000899243-22-020944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020944","line_url":"/filing/0000899243-22-020944#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2327.0,"shares_display":"2,327","price_per_share":0.6424,"price_display":"0.64","price_state":"stated","total_value":1494.8648,"total_display":"1,494.86","total_whole":"1,495","shares_owned_after":281518.0,"shares_owned_after_display":"281,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6741145,"accession":"0000899243-22-016297","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016297","line_url":"/filing/0000899243-22-016297","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3733.0,"shares_display":"3,733","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":7353.2634,"total_display":"7,353.26","total_whole":"7,353","shares_owned_after":278783.0,"shares_owned_after_display":"278,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider","n_lines":2},{"id":6471345,"accession":"0000899243-22-009065","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-009065","line_url":"/filing/0000899243-22-009065","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10770.0,"shares_display":"10,770","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":20096.82,"total_display":"20,096.82","total_whole":"20,097","shares_owned_after":274142.0,"shares_owned_after_display":"274,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":6559869,"accession":"0000899243-22-004577","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-004577","line_url":"/filing/0000899243-22-004577","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4442.0,"shares_display":"4,442","price_per_share":1.93971044574516,"price_display":"1.94","price_state":"stated","total_value":8616.1938,"total_display":"8,616.19","total_whole":"8,616","shares_owned_after":263974.0,"shares_owned_after_display":"263,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider","n_lines":2},{"id":5039192,"accession":"0000899243-21-046767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046767","line_url":"/filing/0000899243-21-046767#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":304.0,"shares_display":"304","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":912.0,"total_display":"912.00","total_whole":"912","shares_owned_after":260041.0,"shares_owned_after_display":"260,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider"},{"id":5238185,"accession":"0000899243-21-042709","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-042709","line_url":"/filing/0000899243-21-042709","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3696.0,"shares_display":"3,696","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":16816.8,"total_display":"16,816.80","total_whole":"16,817","shares_owned_after":259658.0,"shares_owned_after_display":"259,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":4267292,"accession":"0000899243-21-035116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-035116","line_url":"/filing/0000899243-21-035116#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":304.0,"shares_display":"304","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1486.56,"total_display":"1,486.56","total_whole":"1,487","shares_owned_after":254980.0,"shares_owned_after_display":"254,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5328188,"accession":"0000899243-21-031447","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-031447","line_url":"/filing/0000899243-21-031447","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3683.0,"shares_display":"3,683","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":17752.06,"total_display":"17,752.06","total_whole":"17,752","shares_owned_after":254596.0,"shares_owned_after_display":"254,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider","n_lines":2},{"id":4661496,"accession":"0000899243-21-021854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-021854","line_url":"/filing/0000899243-21-021854#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":283.0,"shares_display":"283","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":1593.29,"total_display":"1,593.29","total_whole":"1,593","shares_owned_after":249905.0,"shares_owned_after_display":"249,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-03","scope":"insider"},{"id":4508728,"accession":"0000899243-21-018279","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-018279","line_url":"/filing/0000899243-21-018279","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3952.0,"shares_display":"3,952","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":21894.08,"total_display":"21,894.08","total_whole":"21,894","shares_owned_after":249501.0,"shares_owned_after_display":"249,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider","n_lines":2},{"id":4759723,"accession":"0000899243-21-009502","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-009502","line_url":"/filing/0000899243-21-009502","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":580.0,"shares_display":"580","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":3648.2,"total_display":"3,648.20","total_whole":"3,648","shares_owned_after":245079.0,"shares_owned_after_display":"245,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":4920356,"accession":"0000899243-21-004673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-004673","line_url":"/filing/0000899243-21-004673","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10990.0,"shares_display":"10,990","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":87590.3,"total_display":"87,590.30","total_whole":"87,590","shares_owned_after":244346.0,"shares_owned_after_display":"244,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":2067084,"accession":"0000899243-20-034997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034997","line_url":"/filing/0000899243-20-034997#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":4708.72,"total_display":"4,708.72","total_whole":"4,709","shares_owned_after":233086.0,"shares_owned_after_display":"233,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":2045373,"accession":"0000899243-20-032935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032935","line_url":"/filing/0000899243-20-032935","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":581.0,"shares_display":"581","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":2841.09,"total_display":"2,841.09","total_whole":"2,841","shares_owned_after":215522.0,"shares_owned_after_display":"215,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider","n_lines":2},{"id":2329586,"accession":"0000899243-20-030473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030473","line_url":"/filing/0000899243-20-030473#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1689.0,"shares_display":"1,689","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":8326.77,"total_display":"8,326.77","total_whole":"8,327","shares_owned_after":214791.0,"shares_owned_after_display":"214,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2732431,"accession":"0000899243-20-026082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-026082","line_url":"/filing/0000899243-20-026082","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":838.0,"shares_display":"838","price_per_share":6.850107398568019,"price_display":"6.85","price_state":"stated","total_value":5740.39,"total_display":"5,740.39","total_whole":"5,740","shares_owned_after":212731.0,"shares_owned_after_display":"212,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-23","scope":"insider","n_lines":2},{"id":2513287,"accession":"0000899243-20-024508","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-024508","line_url":"/filing/0000899243-20-024508","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":553.0,"shares_display":"553","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":2930.9,"total_display":"2,930.90","total_whole":"2,931","shares_owned_after":211694.0,"shares_owned_after_display":"211,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider","n_lines":2},{"id":2632791,"accession":"0000899243-20-021478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-021478","line_url":"/filing/0000899243-20-021478#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1670.0,"shares_display":"1,670","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":9886.4,"total_display":"9,886.40","total_whole":"9,886","shares_owned_after":210934.0,"shares_owned_after_display":"210,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2418841,"accession":"0000899243-20-017486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017486","line_url":"/filing/0000899243-20-017486#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":5587.46,"total_display":"5,587.46","total_whole":"5,587","shares_owned_after":208855.0,"shares_owned_after_display":"208,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-23","scope":"insider"},{"id":3195302,"accession":"0000899243-20-015502","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015502","line_url":"/filing/0000899243-20-015502","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":598.0,"shares_display":"598","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":4203.94,"total_display":"4,203.94","total_whole":"4,204","shares_owned_after":207809.0,"shares_owned_after_display":"207,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider","n_lines":2},{"id":2328414,"accession":"0000899243-20-012239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-012239","line_url":"/filing/0000899243-20-012239#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1475.0,"shares_display":"1,475","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":11947.5,"total_display":"11,947.50","total_whole":"11,948","shares_owned_after":207095.0,"shares_owned_after_display":"207,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2132570,"accession":"0000899243-20-009259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009259","line_url":"/filing/0000899243-20-009259#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":3813.4,"total_display":"3,813.40","total_whole":"3,813","shares_owned_after":204821.0,"shares_owned_after_display":"204,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-23","scope":"insider"},{"id":2168793,"accession":"0000899243-20-007185","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-007185","line_url":"/filing/0000899243-20-007185","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":4356.0,"total_display":"4,356.00","total_whole":"4,356","shares_owned_after":203775.0,"shares_owned_after_display":"203,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider","n_lines":2},{"id":2677248,"accession":"0000899243-20-003481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-003481","line_url":"/filing/0000899243-20-003481#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7204.0,"shares_display":"7,204","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":60585.64,"total_display":"60,585.64","total_whole":"60,586","shares_owned_after":203067.0,"shares_owned_after_display":"203,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":8438343,"accession":"0000899243-19-030053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-030053","line_url":"/filing/0000899243-19-030053#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":830.0,"shares_display":"830","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":9379.0,"total_display":"9,379.00","total_whole":"9,379","shares_owned_after":195274.0,"shares_owned_after_display":"195,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-26","scope":"insider"},{"id":8115136,"accession":"0000899243-19-028562","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028562","line_url":"/filing/0000899243-19-028562","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":592.0,"shares_display":"592","price_per_share":14.594763513513513,"price_display":"14.59","price_state":"stated","total_value":8640.1,"total_display":"8,640.10","total_whole":"8,640","shares_owned_after":194229.0,"shares_owned_after_display":"194,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider","n_lines":2},{"id":8437978,"accession":"0000899243-19-024172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-024172","line_url":"/filing/0000899243-19-024172#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":837.0,"shares_display":"837","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":4017.6,"total_display":"4,017.60","total_whole":"4,018","shares_owned_after":193509.0,"shares_owned_after_display":"193,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8761791,"accession":"0000899243-19-023018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-023018","line_url":"/filing/0000899243-19-023018","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630.0,"shares_display":"630","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":3282.3,"total_display":"3,282.30","total_whole":"3,282","shares_owned_after":192471.0,"shares_owned_after_display":"192,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider","n_lines":2},{"id":8273431,"accession":"0000899243-19-017948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-017948","line_url":"/filing/0000899243-19-017948#line-2","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":14.7,"price_display":"14.70","price_state":"stated","total_value":12186.3,"total_display":"12,186.30","total_whole":"12,186","shares_owned_after":191788.0,"shares_owned_after_display":"191,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider"},{"id":8608455,"accession":"0000899243-19-015791","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-015791","line_url":"/filing/0000899243-19-015791#line-4","is_derivative":false,"issuer_cik":"0001268304","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001268304","owner_cik":"0001268304","owner_name":"IVERS-READ GILLIAN C","owner_display_name":"IVERS-READ GILLIAN C","owner_url":"/insider/0001268304","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302.0,"shares_display":"302","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":4551.14,"total_display":"4,551.14","total_whole":"4,551","shares_owned_after":190742.0,"shares_owned_after_display":"190,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"}],"collapsed":true,"next_cursor":"2019-06-04|8608455","ledger_fault":false,"count":{"value":92,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":91,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":92},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":52,"first_seen":"2011-11-21","last_seen":"2022-11-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001203866","name":"PHARMION CORP","url":"/issuer/0001203866","role":"Officer (EVP, Development Operations)","n_filings":3,"first_seen":"2004-12-13","last_seen":"2007-08-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001268304","retrieved_at":"2026-08-23T12:29:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}